Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Madrigal Pharmaceuticals Inc shares valued at $1,691,100 were purchased by RICHARD S LEVY on Nov 07 ’24. At $338.22 per share, RICHARD S LEVY acquired 5,000 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Levy Richard S sold 5,000 shares, netting a total of over 1,504,703 in proceeds. Following the sale of shares at $300.94 each, the insider now holds 11,012 shares.
Before that, RICHARD S LEVY had added 5,000 shares to its account. In a trade valued at $1,296,700, the Director bought Madrigal Pharmaceuticals Inc shares for $259.34 each.
As published in their initiating research note from Cantor Fitzgerald on June 28, 2024, Madrigal Pharmaceuticals Inc [MDGL] has been a Neutral. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid June. As of April 22, 2024, BofA Securities has initiated its “an Underperform” rating for MDGL. Earlier on March 15, 2024, B. Riley Securities upgraded its rating. Their new recommendation was “a Neutral” for MDGL stock which previously was a “a Sell”.
Analyzing MDGL Stock Performance
During the last five days, there has been a surge of approximately 36.83%. Over the course of the year, Madrigal Pharmaceuticals Inc shares have jumped approximately 53.36%. Shares of the company reached a 52-week high of $368.29 on 11/07/24 and a 52-week low of $168.25 on 02/09/24. A 50-day SMA is recorded $234.47, while a 200-day SMA reached $243.29. Nevertheless, trading volume fell to 0.68 million shares from 0.59 million shares the previous day.
Support And Resistance Levels for Madrigal Pharmaceuticals Inc (MDGL)
According to the 24-hour chart, there is a support level at 338.80, which, if violated, would cause prices to drop to 322.75. In the upper region, resistance lies at 369.60. The next price resistance is at 384.34. RSI (Relative Strength Index) is 88.89 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 84.97, which suggests the price will increase in the coming days. Percent R is at 8.02%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
